menu
    • menu

    Company profile for ExeVir Bio

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ExeVir Bio, a spin out of VIB, is harnessing its Llama-derived antibody (VHH) technology platform to generate robust antiviral therapies providing broad protection against coronaviruses. ExeVir Bio is using a highly innovative and clinically validated VHH technology to develop treatments for viral infections that may pose a significant global threat. Our lead compound, an enhanced variant of VHH72-Fc binds to a unique epito...
    ExeVir Bio, a spin out of VIB, is harnessing its Llama-derived antibody (VHH) technology platform to generate robust antiviral therapies providing broad protection against coronaviruses. ExeVir Bio is using a highly innovative and clinically validated VHH technology to develop treatments for viral infections that may pose a significant global threat. Our lead compound, an enhanced variant of VHH72-Fc binds to a unique epitope that is conserved in SARS-CoV-1 and SARS-CoV-2 viruses and this binding prevents these viruses from entering the cell. The importance of this approach is that it could be used both as a therapeutic and prophylactic.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ExeVir BioBelgium Flag
    Country
    Country
    Belgium
    Address
    Address
    Rijvisschestraat 120 9052 Ghent
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://exevir.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/exevir/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ExeVir Announces Michael Garrett as New Chief Executive Officer
    ExeVir Announces Michael Garrett as New Chief Executive Officer

    18 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/18/2982468/0/en/ExeVir-Announces-Michael-Garrett-as-New-Chief-Executive-Officer.html

    GLOBENEWSWIRE
    18 Nov 2024
    Share Share
    ExeVir Bio presents promising XVR013m data at ID Week 2024
    ExeVir Bio presents promising XVR013m data at ID Week 2024

    17 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/17/2964613/0/en/Empowering-the-Immunocompromised-and-Elderly-ExeVir-Bio-presents-promising-XVR013m-data-at-ID-Week-2024.html

    GLOBENEWSWIRE
    17 Oct 2024
    Share Share
    ExeVir Bio: XVR013m Potent Against SARS-CoV-2 Variant JN1
    ExeVir Bio: XVR013m Potent Against SARS-CoV-2 Variant JN1

    04 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/04/2892776/0/en/ExeVir-Bio-Announces-Exceptional-Virus-Neutralization-Potency-of-its-Variant-proof-XVR013m-Antibody-Against-the-SARS-CoV-2-Variant-JN-1.html

    GLOBENEWSWIRE
    04 Jun 2024
    Share Share
    ExeVir Bio Announces Positive Virus Neutralization Data for XVR012
    ExeVir Bio Announces Positive Virus Neutralization Data for XVR012

    15 Jan 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/01/15/2808967/0/en/ExeVir-Bio-Announces-Positive-Virus-Neutralization-Data-for-XVR012-Against-Emerging-COVID-19-Omicron-Variants.html

    GLOBENEWSWIRE
    15 Jan 2024
    Share Share
    ExeVir Bio Awarded EUR 1.6m Grant for Dengue Research
    ExeVir Bio Awarded EUR 1.6m Grant for Dengue Research

    28 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/28/2695913/0/en/ExeVir-Bio-Awarded-EUR-1-6m-Grant-for-Dengue-Research.html

    GLOBENEWSWIRE
    28 Jun 2023
    Share Share
    ExeVir Bio and VIB Announce Data on a New Therapy for Treatment for COVID-19
    ExeVir Bio and VIB Announce Data on a New Therapy for Treatment for COVID-19

    13 Mar 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/03/13/2625442/0/en/ExeVir-Bio-and-VIB-Announce-Data-on-a-New-Therapy-for-Prevention-and-Treatment-for-COVID-19.html

    GLOBENEWSWIRE
    13 Mar 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search